# Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

> PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41944182-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-14
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41944182-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41944182-tirzepatide-v1.json
- Content SHA-256: `78b8bba33ada9dbe81a12dd96436470adadc6b4a4c0b0976e4c9d907e7828d0c`

## Claims and source pins

### Headline

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study. ([`pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec`](#source-pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec))

### Summary

PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec`](#source-pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec))

### Paragraph 1

PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec`](#source-pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec`](#source-pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec))

## Sources

<a id="source-pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec"></a>
- **Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study. · retained source version 1:2026-07-14:current:9e8d0b6dc0ec5b29af04dce66a3650b6bec9431ade474120a354b9f8c093b70e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41944182/) (`pubmed-observation-pmid-41944182-2026-07-14-9e8d0b6dc0ec`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41944182-tirzepatide-v1.json SHA-256: 78b8bba33ada9dbe81a12dd96436470adadc6b4a4c0b0976e4c9d907e7828d0c.